<DOC>
	<DOCNO>NCT01436266</DOCNO>
	<brief_summary>Misoprostol medication use extensively obstetrics gynecology ability aid softening cervix well decrease blood loss abortion vaginal delivery . Opinions vary usefulness aid cervical dilation , decrease blood loss . The investigator propose conduct randomize , placebo-controlled trial evaluate whether misoprostol give buccally 2 hour prior second trimester surgical abortion decrease blood loss procedure . The investigator also assess whether misoprostol improve cervical dilation , change length procedure , change need additional mechanical dilation , change subjective ease procedure , change woman 's pain .</brief_summary>
	<brief_title>Effect Preoperative Buccal Misoprostol Blood Loss Second-trimester Dilation Evacuation Abortion</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>English Spanish speaking Gestational age 16 week 6 day 20 week 6 day gestation ultrasound date day enrollment Ultrasound use date purpose must within last two week . Women 1850 year age undergoing surgical termination pregnancy Spontaneous fetal demise Ruptured membrane intrauterine infection Fibroids significantly distort uterine shape Uterine abnormality unicornuate uterus Prior transmural myomectomy Severe oligohydramnios Morbid obesity BMI &gt; 45 Inability place osmotic dilator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>